Medical Care

Global Endothelial Dysfunction Market Research Report 2024

Endothelium is an inert lining of the blood vessels which act as highly specialized and metabolically active interface between the blood and the underlying tissues. The basic activities of endothelium encompass mediation of coagulation, platelet adhesion, immune function and control of volume and electrolyte content of the intravascular and extravascular spaces. Endothelium dysfunction can be defined as partial or complete loss of balance between vasodilating and vasoconstricting substances produced by the endothelium.
The global Endothelial Dysfunction market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Geographically, the North American and European markets are currently the major markets for endothelial dysfunction products due to their high R&D involvement, advanced medical facilities, and wide awareness of cardiovascular diseases and other related diseases. Lack of government intervention and funding for R&D affects growth and income shares in emerging and developing countries. With the substantial increase in cardiovascular and diabetes cases in Asia Pacific and Middle East countries in the coming years, the demand for the endothelial dysfunction market in these regions is likely to grow over the next seven years.
This report aims to provide a comprehensive presentation of the global market for Endothelial Dysfunction, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Endothelial Dysfunction.
Report Scope
The Endothelial Dysfunction market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Endothelial Dysfunction market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Endothelial Dysfunction companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Chugai Pharmaceutical
Johnson & Johnson
Glucox Biotech AB
Stealth Peptides
Segment by Type
Western Medicine Treatment
Chinese Medicine Treatment
Segment by Application
Hospital
Clinic
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Endothelial Dysfunction companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Endothelial Dysfunction Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Western Medicine Treatment
1.2.3 Chinese Medicine Treatment
1.3 Market by Application
1.3.1 Global Endothelial Dysfunction Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Endothelial Dysfunction Market Perspective (2019-2030)
2.2 Endothelial Dysfunction Growth Trends by Region
2.2.1 Global Endothelial Dysfunction Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Endothelial Dysfunction Historic Market Size by Region (2019-2024)
2.2.3 Endothelial Dysfunction Forecasted Market Size by Region (2025-2030)
2.3 Endothelial Dysfunction Market Dynamics
2.3.1 Endothelial Dysfunction Industry Trends
2.3.2 Endothelial Dysfunction Market Drivers
2.3.3 Endothelial Dysfunction Market Challenges
2.3.4 Endothelial Dysfunction Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Endothelial Dysfunction Players by Revenue
3.1.1 Global Top Endothelial Dysfunction Players by Revenue (2019-2024)
3.1.2 Global Endothelial Dysfunction Revenue Market Share by Players (2019-2024)
3.2 Global Endothelial Dysfunction Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Endothelial Dysfunction Revenue
3.4 Global Endothelial Dysfunction Market Concentration Ratio
3.4.1 Global Endothelial Dysfunction Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Endothelial Dysfunction Revenue in 2023
3.5 Endothelial Dysfunction Key Players Head office and Area Served
3.6 Key Players Endothelial Dysfunction Product Solution and Service
3.7 Date of Enter into Endothelial Dysfunction Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Endothelial Dysfunction Breakdown Data by Type
4.1 Global Endothelial Dysfunction Historic Market Size by Type (2019-2024)
4.2 Global Endothelial Dysfunction Forecasted Market Size by Type (2025-2030)
5 Endothelial Dysfunction Breakdown Data by Application
5.1 Global Endothelial Dysfunction Historic Market Size by Application (2019-2024)
5.2 Global Endothelial Dysfunction Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Endothelial Dysfunction Market Size (2019-2030)
6.2 North America Endothelial Dysfunction Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Endothelial Dysfunction Market Size by Country (2019-2024)
6.4 North America Endothelial Dysfunction Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Endothelial Dysfunction Market Size (2019-2030)
7.2 Europe Endothelial Dysfunction Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Endothelial Dysfunction Market Size by Country (2019-2024)
7.4 Europe Endothelial Dysfunction Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Endothelial Dysfunction Market Size (2019-2030)
8.2 Asia-Pacific Endothelial Dysfunction Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Endothelial Dysfunction Market Size by Region (2019-2024)
8.4 Asia-Pacific Endothelial Dysfunction Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Endothelial Dysfunction Market Size (2019-2030)
9.2 Latin America Endothelial Dysfunction Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Endothelial Dysfunction Market Size by Country (2019-2024)
9.4 Latin America Endothelial Dysfunction Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Endothelial Dysfunction Market Size (2019-2030)
10.2 Middle East & Africa Endothelial Dysfunction Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Endothelial Dysfunction Market Size by Country (2019-2024)
10.4 Middle East & Africa Endothelial Dysfunction Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Endothelial Dysfunction Introduction
11.1.4 Abbott Laboratories Revenue in Endothelial Dysfunction Business (2019-2024)
11.1.5 Abbott Laboratories Recent Development
11.2 Chugai Pharmaceutical
11.2.1 Chugai Pharmaceutical Company Detail
11.2.2 Chugai Pharmaceutical Business Overview
11.2.3 Chugai Pharmaceutical Endothelial Dysfunction Introduction
11.2.4 Chugai Pharmaceutical Revenue in Endothelial Dysfunction Business (2019-2024)
11.2.5 Chugai Pharmaceutical Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Detail
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Endothelial Dysfunction Introduction
11.3.4 Johnson & Johnson Revenue in Endothelial Dysfunction Business (2019-2024)
11.3.5 Johnson & Johnson Recent Development
11.4 Glucox Biotech AB
11.4.1 Glucox Biotech AB Company Detail
11.4.2 Glucox Biotech AB Business Overview
11.4.3 Glucox Biotech AB Endothelial Dysfunction Introduction
11.4.4 Glucox Biotech AB Revenue in Endothelial Dysfunction Business (2019-2024)
11.4.5 Glucox Biotech AB Recent Development
11.5 Stealth Peptides
11.5.1 Stealth Peptides Company Detail
11.5.2 Stealth Peptides Business Overview
11.5.3 Stealth Peptides Endothelial Dysfunction Introduction
11.5.4 Stealth Peptides Revenue in Endothelial Dysfunction Business (2019-2024)
11.5.5 Stealth Peptides Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Endothelial Dysfunction Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Western Medicine Treatment
Table 3. Key Players of Chinese Medicine Treatment
Table 4. Global Endothelial Dysfunction Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Endothelial Dysfunction Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Endothelial Dysfunction Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Endothelial Dysfunction Market Share by Region (2019-2024)
Table 8. Global Endothelial Dysfunction Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Endothelial Dysfunction Market Share by Region (2025-2030)
Table 10. Endothelial Dysfunction Market Trends
Table 11. Endothelial Dysfunction Market Drivers
Table 12. Endothelial Dysfunction Market Challenges
Table 13. Endothelial Dysfunction Market Restraints
Table 14. Global Endothelial Dysfunction Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Endothelial Dysfunction Market Share by Players (2019-2024)
Table 16. Global Top Endothelial Dysfunction Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endothelial Dysfunction as of 2023)
Table 17. Ranking of Global Top Endothelial Dysfunction Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Endothelial Dysfunction Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Endothelial Dysfunction Product Solution and Service
Table 21. Date of Enter into Endothelial Dysfunction Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Endothelial Dysfunction Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Endothelial Dysfunction Revenue Market Share by Type (2019-2024)
Table 25. Global Endothelial Dysfunction Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Endothelial Dysfunction Revenue Market Share by Type (2025-2030)
Table 27. Global Endothelial Dysfunction Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Endothelial Dysfunction Revenue Market Share by Application (2019-2024)
Table 29. Global Endothelial Dysfunction Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Endothelial Dysfunction Revenue Market Share by Application (2025-2030)
Table 31. North America Endothelial Dysfunction Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Endothelial Dysfunction Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Endothelial Dysfunction Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Endothelial Dysfunction Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Endothelial Dysfunction Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Endothelial Dysfunction Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Endothelial Dysfunction Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Endothelial Dysfunction Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Endothelial Dysfunction Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Endothelial Dysfunction Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Endothelial Dysfunction Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Endothelial Dysfunction Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Endothelial Dysfunction Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Endothelial Dysfunction Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Endothelial Dysfunction Market Size by Country (2025-2030) & (US$ Million)
Table 46. Abbott Laboratories Company Detail
Table 47. Abbott Laboratories Business Overview
Table 48. Abbott Laboratories Endothelial Dysfunction Product
Table 49. Abbott Laboratories Revenue in Endothelial Dysfunction Business (2019-2024) & (US$ Million)
Table 50. Abbott Laboratories Recent Development
Table 51. Chugai Pharmaceutical Company Detail
Table 52. Chugai Pharmaceutical Business Overview
Table 53. Chugai Pharmaceutical Endothelial Dysfunction Product
Table 54. Chugai Pharmaceutical Revenue in Endothelial Dysfunction Business (2019-2024) & (US$ Million)
Table 55. Chugai Pharmaceutical Recent Development
Table 56. Johnson & Johnson Company Detail
Table 57. Johnson & Johnson Business Overview
Table 58. Johnson & Johnson Endothelial Dysfunction Product
Table 59. Johnson & Johnson Revenue in Endothelial Dysfunction Business (2019-2024) & (US$ Million)
Table 60. Johnson & Johnson Recent Development
Table 61. Glucox Biotech AB Company Detail
Table 62. Glucox Biotech AB Business Overview
Table 63. Glucox Biotech AB Endothelial Dysfunction Product
Table 64. Glucox Biotech AB Revenue in Endothelial Dysfunction Business (2019-2024) & (US$ Million)
Table 65. Glucox Biotech AB Recent Development
Table 66. Stealth Peptides Company Detail
Table 67. Stealth Peptides Business Overview
Table 68. Stealth Peptides Endothelial Dysfunction Product
Table 69. Stealth Peptides Revenue in Endothelial Dysfunction Business (2019-2024) & (US$ Million)
Table 70. Stealth Peptides Recent Development
Table 71. Research Programs/Design for This Report
Table 72. Key Data Information from Secondary Sources
Table 73. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Endothelial Dysfunction Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Endothelial Dysfunction Market Share by Type: 2023 VS 2030
Figure 3. Western Medicine Treatment Features
Figure 4. Chinese Medicine Treatment Features
Figure 5. Global Endothelial Dysfunction Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Endothelial Dysfunction Market Share by Application: 2023 VS 2030
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Endothelial Dysfunction Report Years Considered
Figure 10. Global Endothelial Dysfunction Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 11. Global Endothelial Dysfunction Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Endothelial Dysfunction Market Share by Region: 2023 VS 2030
Figure 13. Global Endothelial Dysfunction Market Share by Players in 2023
Figure 14. Global Top Endothelial Dysfunction Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endothelial Dysfunction as of 2023)
Figure 15. The Top 10 and 5 Players Market Share by Endothelial Dysfunction Revenue in 2023
Figure 16. North America Endothelial Dysfunction Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 17. North America Endothelial Dysfunction Market Share by Country (2019-2030)
Figure 18. United States Endothelial Dysfunction Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. Canada Endothelial Dysfunction Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Europe Endothelial Dysfunction Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Endothelial Dysfunction Market Share by Country (2019-2030)
Figure 22. Germany Endothelial Dysfunction Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. France Endothelial Dysfunction Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. U.K. Endothelial Dysfunction Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Italy Endothelial Dysfunction Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Russia Endothelial Dysfunction Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Nordic Countries Endothelial Dysfunction Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Asia-Pacific Endothelial Dysfunction Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Endothelial Dysfunction Market Share by Region (2019-2030)
Figure 30. China Endothelial Dysfunction Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Japan Endothelial Dysfunction Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. South Korea Endothelial Dysfunction Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Southeast Asia Endothelial Dysfunction Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. India Endothelial Dysfunction Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Australia Endothelial Dysfunction Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Latin America Endothelial Dysfunction Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Endothelial Dysfunction Market Share by Country (2019-2030)
Figure 38. Mexico Endothelial Dysfunction Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Brazil Endothelial Dysfunction Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Middle East & Africa Endothelial Dysfunction Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Endothelial Dysfunction Market Share by Country (2019-2030)
Figure 42. Turkey Endothelial Dysfunction Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Saudi Arabia Endothelial Dysfunction Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Abbott Laboratories Revenue Growth Rate in Endothelial Dysfunction Business (2019-2024)
Figure 45. Chugai Pharmaceutical Revenue Growth Rate in Endothelial Dysfunction Business (2019-2024)
Figure 46. Johnson & Johnson Revenue Growth Rate in Endothelial Dysfunction Business (2019-2024)
Figure 47. Glucox Biotech AB Revenue Growth Rate in Endothelial Dysfunction Business (2019-2024)
Figure 48. Stealth Peptides Revenue Growth Rate in Endothelial Dysfunction Business (2019-2024)
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies